These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 11250674)

  • 1. Killing the umpire: cooperative defects in mitotic checkpoint and BRCA2 genes on the road to transformation.
    McKeon F
    Breast Cancer Res; 1999; 1(1):8-10. PubMed ID: 11250674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mitotic checkpoint inactivation fosters transformation in cells lacking the breast cancer susceptibility gene, Brca2.
    Lee H; Trainer AH; Friedman LS; Thistlethwaite FC; Evans MJ; Ponder BA; Venkitaraman AR
    Mol Cell; 1999 Jul; 4(1):1-10. PubMed ID: 10445022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impaired phosphorylation and mis-localization of Bub1 and BubR1 are responsible for the defective mitotic checkpoint function in Brca2-mutant thymic lymphomas.
    Lee H
    Exp Mol Med; 2003 Oct; 35(5):448-53. PubMed ID: 14646599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased expression of mitotic checkpoint genes in breast cancer cells with chromosomal instability.
    Yuan B; Xu Y; Woo JH; Wang Y; Bae YK; Yoon DS; Wersto RP; Tully E; Wilsbach K; Gabrielson E
    Clin Cancer Res; 2006 Jan; 12(2):405-10. PubMed ID: 16428479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BRCA2 and p53 mutations in primary breast cancer in relation to genetic instability.
    Gretarsdottir S; Thorlacius S; Valgardsdottir R; Gudlaugsdottir S; Sigurdsson S; Steinarsdottir M; Jonasson JG; Anamthawat-Jonsson K; Eyfjörd JE
    Cancer Res; 1998 Mar; 58(5):859-62. PubMed ID: 9500438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased frequency of TP53 mutations in BRCA1 and BRCA2 ovarian tumours.
    Ramus SJ; Bobrow LG; Pharoah PD; Finnigan DS; Fishman A; Altaras M; Harrington PA; Gayther SA; Ponder BA; Friedman LS
    Genes Chromosomes Cancer; 1999 Jun; 25(2):91-6. PubMed ID: 10337991
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathology of familial breast cancer: differences between breast cancers in carriers of BRCA1 or BRCA2 mutations and sporadic cases. Breast Cancer Linkage Consortium.
    Lancet; 1997 May; 349(9064):1505-10. PubMed ID: 9167459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor suppressor genes and breast cancer.
    Buchholz TA; Weil MM; Story MD; Strom EA; Brock WA; McNeese MD
    Radiat Oncol Investig; 1999; 7(2):55-65. PubMed ID: 10333246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The pathology of familial breast cancer: How do the functions of BRCA1 and BRCA2 relate to breast tumour pathology?
    Bertwistle D; Ashworth A
    Breast Cancer Res; 1999; 1(1):41-7. PubMed ID: 11250682
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stable interaction between the products of the BRCA1 and BRCA2 tumor suppressor genes in mitotic and meiotic cells.
    Chen J; Silver DP; Walpita D; Cantor SB; Gazdar AF; Tomlinson G; Couch FJ; Weber BL; Ashley T; Livingston DM; Scully R
    Mol Cell; 1998 Sep; 2(3):317-28. PubMed ID: 9774970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumorigenesis and a DNA repair defect in mice with a truncating Brca2 mutation.
    Connor F; Bertwistle D; Mee PJ; Ross GM; Swift S; Grigorieva E; Tybulewicz VL; Ashworth A
    Nat Genet; 1997 Dec; 17(4):423-30. PubMed ID: 9398843
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Absence of Brca2 causes genome instability by chromosome breakage and loss associated with centrosome amplification.
    Tutt A; Gabriel A; Bertwistle D; Connor F; Paterson H; Peacock J; Ross G; Ashworth A
    Curr Biol; 1999 Oct; 9(19):1107-10. PubMed ID: 10531007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiple copies of mutant BRCA1 and BRCA2 alleles in breast tumors from germ-line mutation carriers.
    Staff S; Nupponen NN; Borg A; Isola JJ; Tanner MM
    Genes Chromosomes Cancer; 2000 Aug; 28(4):432-42. PubMed ID: 10862052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Possible causes of chromosome instability: comparison of chromosomal abnormalities in cancer cell lines with mutations in BRCA1, BRCA2, CHK2 and BUB1.
    Grigorova M; Staines JM; Ozdag H; Caldas C; Edwards PA
    Cytogenet Genome Res; 2004; 104(1-4):333-40. PubMed ID: 15162061
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lessons learned from BRCA1 and BRCA2.
    Zheng L; Li S; Boyer TG; Lee WH
    Oncogene; 2000 Dec; 19(53):6159-75. PubMed ID: 11156530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinico-pathological characteristics of BRCA1- and BRCA2-related breast cancer.
    Chappuis PO; Nethercot V; Foulkes WD
    Semin Surg Oncol; 2000 Jun; 18(4):287-95. PubMed ID: 10805950
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Brca1 and Brca2 proteins and tumor pathogenesis.
    Ingvarsson S
    Anticancer Res; 1999; 19(4B):2853-61. PubMed ID: 10652564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutation and expression analysis of human BUB1 and BUB1B in aneuploid breast cancer cell lines.
    Myrie KA; Percy MJ; Azim JN; Neeley CK; Petty EM
    Cancer Lett; 2000 May; 152(2):193-9. PubMed ID: 10773412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of allelic imbalance at locus D13S171 (BRCA2) and p53 alterations with tumor kinetics and chromosomal instability (aneuploidy) in nonsmall cell lung carcinoma.
    Gorgoulis VG; Kotsinas A; Zacharatos P; Mariatos G; Liloglou T; Tsoli E; Kokotas S; Fassoulas C; Field JK; Kittas C
    Cancer; 2000 Nov; 89(9):1933-45. PubMed ID: 11064350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nonhomologous end-joining of ionizing radiation-induced DNA double-stranded breaks in human tumor cells deficient in BRCA1 or BRCA2.
    Wang H; Zeng ZC; Bui TA; DiBiase SJ; Qin W; Xia F; Powell SN; Iliakis G
    Cancer Res; 2001 Jan; 61(1):270-7. PubMed ID: 11196174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.